522 Results

People

  1. De Angelis
    De Angelis
  2. Kris
    Kris
  3. Motzer
    Motzer
  4. Livingston
    Livingston
  5. Aghajanian
    Aghajanian
  6. Krown
    Krown
  7. Panageas
    Panageas
  8. Miller
    Miller
  9. Tyson
    Tyson
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)
  7. Tow Center for Developmental Oncology (TCDO) (51)
  8. Epidemiology and Biostatistics (49)
  9. Population Sciences Research Program (45)
  10. Genitourinary Oncology Service (41)
  1. "headache"
Formats
  1. Journal Article (491)
  2. Review (17)
  3. Research Letter (5)
  4. Conference Paper (3)
  5. Editorial (3)
  6. Book Whole (1)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)

More Groups

People
  1. Lisa De Angelis (20)
  2. Mark Kris (20)
  3. Robert Motzer (19)
  4. Philip Livingston (13)
  5. Carol Aghajanian (12)
  6. Katherine Panageas (12)

More People

Years
  1. 2025 (15)
  2. 2024 (34)
  3. 2023 (30)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (23)
  3. Lancet Oncology (20)
  4. Blood (18)
  5. New England Journal of Medicine (17)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Elsevier Science, Inc. (43)
  3. Springer (42)
  4. American Society of Clinical Oncology (37)
  5. Nature Publishing Group (32)
  6. Oxford University Press (29)

More Publishers

Results (522)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City
    Journal Article

    Jimenez‐Kurlander, L.; Antal, Z.; DeRosa, A.; Diotallevi, D.; Pottenger, E.; Wilson, N.; Corcoran, S.; Boulad, F.; Friedman, D. N.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: An open-label, multicentre, phase 1b study
    Journal Article

    O'Hara, M. H.; O'Reilly, E. M.; Varadhachary, G.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; Cabanski, C. R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
    Journal Article

    Alsina, M.; Landgren, O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J. G.; Kovacsovics, T.; Vesole, D. H.; Fang, B.; Kimball, A. S.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Tazemetostat for patients with relapsed or refractory follicular lymphoma: An open-label, single-arm, multicentre, phase 2 trial
    Journal Article

    Morschhauser, F.; Tilly, H.; Chaidos, A.; McKay, P.; Phillips, T.; Assouline, S.; Batlevi, C. L.; Campbell, P.; Ribrag, V.; Damaj, G. L.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: An international, open-label, phase 2 basket study
    Journal Article

    Gounder, M.; Schöffski, P.; Jones, R. L.; Agulnik, M.; Cote, G. M.; Villalobos, V. M.; Attia, S.; Chugh, R.; Chen, T. W. W.; Jahan, T.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
    Journal Article

    Oaknin, A.; Friedman, C. F.; Roman, L. D.; D'Souza, A.; Brana, I.; Bidard, F. C.; Goldman, J.; Alvarez, E. A.; Boni, V.; ElNaggar, A. C.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of ruxolitinib treatment for polycythemia vera
    Journal Article

    Coltoff, A.; Mesa, R.; Gotlib, J.; Shulman, J.; Rampal, R. K.; Siwoski, O.; Yacoub, A.; Moliterno, A.; Yang, A.; Braunstein, E.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG Oncology/Gynecologic Oncology Group study
    Journal Article

    Huh, W. K.; Brady, W. E.; Fracasso, P. M.; Dizon, D. S.; Powell, M. A.; Monk, B. J.; Leath, C. A. 3rd; Landrum, L. M.; Tanner, E. J.; Crane, E. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET-altered thyroid cancers
    Journal Article

    Wirth, L. J.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Patel, J.; Leboulleux, S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Johnson, M.; Gainor, J.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save